Ronald Ellis
Corporate Officer/Principal at Pacira Pharmaceuticals, Inc. (California)
Net worth: 788 180 $ as of 29/04/2024
Profile
Ronald J.
Ellis is currently a Vice President at Pacira Pharmaceuticals, Inc. He was previously an Independent Director at TELA Bio, Inc. from 2018 to 2020.
He also held positions as a Principal at Wyeth LLC, ABN AMRO Securities (USA), Inc., and Senior Vice President at Leerink Partners LLC.
Ellis received an undergraduate degree and an MBA from St. Joseph's University and a doctorate from Philadelphia College of Osteopathic Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
PACIRA BIOSCIENCES, INC.
0.07% | 06/06/2023 | 30,909 ( 0.07% ) | 788 180 $ | 29/04/2024 |
Ronald Ellis active positions
| Companies | Position | Start |
|---|---|---|
Pacira Pharmaceuticals, Inc. (California)
 Pacira Pharmaceuticals, Inc. (California) Medical SpecialtiesHealth Technology Pacira Pharmaceuticals, Inc. develops and manufactures injectable and sustained release therapeutic products. It focuses on clinical and commercial development activities by understanding the needs of the acute care market. The company was founded in March 2007 and is headquartered in San Diego, CA. | Corporate Officer/Principal | 30/09/2016 |
Former positions of Ronald Ellis
| Companies | Position | End |
|---|---|---|
| TELA BIO, INC. | Director/Board Member | 19/04/2020 |
| ABN AMRO Securities (USA), Inc. | Corporate Officer/Principal | 30/08/2002 |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Corporate Officer/Principal | - |
Leerink Partners LLC
 Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Analyst-Equity | - |
Training of Ronald Ellis
| St. Joseph's University | Masters Business Admin |
| Philadelphia College of Osteopathic Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| TELA BIO, INC. | Health Technology |
| Private companies | 4 |
|---|---|
Leerink Partners LLC
Leerink Partners LLC Investment Banks/BrokersFinance Leerink Partners LLC is a full-service brokerage and investment banking firm headquartered in Boston, Massachusetts. The firm was founded by Jeffrey Leerink in 1995 and formerly known as SVB Securities LLC. They rebranded as Leerink Partners in 2023. The firm is a subsidiary of SVB Securities LLC. Leerink Partners provides institutional sales, equity research, institutional trading, and corporate finance and asset management services to the healthcare and technology industries. They offer superior execution capabilities in common stock, convertibles and derivatives with a singular focus on healthcare and a knowledge-led approach. | Finance |
| ABN AMRO Securities (USA), Inc. | Finance |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
Pacira Pharmaceuticals, Inc. (California)
Pacira Pharmaceuticals, Inc. (California) Medical SpecialtiesHealth Technology Pacira Pharmaceuticals, Inc. develops and manufactures injectable and sustained release therapeutic products. It focuses on clinical and commercial development activities by understanding the needs of the acute care market. The company was founded in March 2007 and is headquartered in San Diego, CA. | Health Technology |
- Stock Market
- Insiders
- Ronald Ellis
